XTLB · Xtl Biopharmaceuticals Ltd · Financials
Market Cap
$6.29M
Shares
2.46M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$451K
FY2024
Net Income
-$6.97M
-578.6%
FY2025
Gross Margin
0.67%
FY2024
Operating Margin
-171.84%
FY2024
Diluted EPS
-$0.01
-300%
FY2025
Operating Cash Flow
-$1.03M
+36.7%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | $451K | — | — | — | — | — | — | — | — | — | |
| — | $448K | — | — | — | — | — | — | — | — | — | |
| — | $3000 | — | — | — | — | — | — | — | — | — | |
| — | 0.67% | — | — | — | — | — | — | — | — | — | |
| $28K | $16K | $31K | $30K | $30K | $38K | $35K | $38K | $43K | $443K | $578K | |
| — | $487K | — | — | — | — | — | — | — | — | — | |
| $1.44M | $759K | $734K | $850K | $1M | $910K | $807K | $755K | $1.2M | $1.27M | $1.42M | |
| — | $199K | — | $1000 | $1000 | $1000 | — | — | $1000 | $3000 | $7000 | |
| -$1.69M | -$775K | -$765K | -$880K | -$1.03M | -$948K | -$842K | -$793K | -$1.25M | -$2.56M | -$3.61M | |
| — | -171.84% | — | — | — | — | — | — | — | — | — | |
| — | -$576K | — | -$879K | -$1.03M | -$947K | — | — | -$1.25M | -$2.56M | -$3.6M | |
| $266K | $112K | $1.06M | $1.56M | $21K | $2.19M | $603K | $35K | $337K | $7000 | $15K | |
| -$759K | $240K | -$1.78M | -$1.35M | — | — | — | — | — | — | — | |
| — | -$130K | — | — | — | — | — | — | — | — | — | |
| -$6.97M | -$1.03M | -$1.78M | -$1.35M | $435K | -$2.95M | -$763K | $3.63M | -$781K | -$2.55M | $2000 | |
| — | -227.72% | — | — | — | — | — | — | — | — | — | |
| USD/shares | -$0.01 | -$0.00 | -$0.00 | -$0.01 | $0.00 | -$0.02 | -$0.00 | — | — | — | — |
| USD/shares | -$0.01 | -$0.00 | -$0.00 | -$0.01 | $0.00 | -$0.02 | -$0.00 | — | — | — | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.